Silexion Therapeutics Corp (SLXNW) › Capital ExpendituresSilexion Therapeutics Corp (SLXNW) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2023: $12.0K2024: $22.0K2025: $9.0K$9.0K2023Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$9.0K-59.1%2024$22.0K+83.3%2023$12.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share